Detalhe da pesquisa
1.
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics.
J Allergy Clin Immunol
; 152(5): 1237-1246, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536512
2.
The effect of immunomodulators on seroconversion after BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study.
Br J Dermatol
; 188(4): 542-551, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36695406
3.
Paradoxical eczema in patients with psoriasis receiving biologics: a case series.
Clin Exp Dermatol
; 47(6): 1174-1178, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150003
4.
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.
Rheumatology (Oxford)
; 60(4): 1588-1592, 2021 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33097948
5.
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs.
Rheumatology (Oxford)
; 61(9): 3514-3520, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640653
6.
The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs.
Rheumatology (Oxford)
; 61(9): e255-e266, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35640657
7.
Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis.
JAMA Dermatol
; 160(1): 71-79, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055239
8.
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics.
J Invest Dermatol
; 143(8): 1470-1478.e1, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804406
9.
Genetic prediction of treatment response in psoriasis is still a work in progress.
Br J Dermatol
; 177(2): 344-345, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28833021
10.
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.
JAMA Dermatol
; 158(5): 561-572, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35353175
11.
Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists.
BioDrugs
; 35(2): 187-199, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33635522
12.
Brodalumab in psoriasis: evidence to date and clinical potential.
Drugs Context
; 8: 212570, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31024633
13.
A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.
J Invest Dermatol
; 139(1): 100-107, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30030151
14.
Research Techniques Made Simple: Bioinformatics for Genome-Scale Biology.
J Invest Dermatol
; 137(9): e163-e168, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28843296
15.
Pharmacogenomics and the resulting impact on psoriasis therapies.
Dermatol Clin
; 33(1): 149-60, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25412789
16.
Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.
Dermatol Ther (Heidelb)
; 4(2): 145-56, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942326
17.
Unmasking of axial spondyloarthritis and oligoarthritis following discontinuation of tumour necrosis factor inhibitor therapy for psoriasis.
J Dermatolog Treat
; 25(1): 61-2, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22812533
18.
Patients' narratives.
Curr Probl Dermatol
; 44: 145-57, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23796819